Drugs / hepatitis B vaccines
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00000583 | Nov 1978 → Jun 1980 | hepatitis B virus infection | National Heart, Lung, and Blood Institute (NHLBI) | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | hepatitis B vaccines | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00000583 ↗ |
| Modality | Vaccine | “vaccine consisting of highly purified, formalin-inactivated HBsAg particles” NCT00000583 ↗ |